Green Square Asset Management »

Regeneron Pharmaceuticals shares owned by Green Square Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Green Square Asset Management from 13F filings

Historical chart of Green Square Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Green Square Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Green Square Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $204k 232 878.29

More positions owned by Green Square Asset Management

Ishares S&p 500 Growth Etf Exchange traded fund (IVW)
Zoominfo Technoligies Common stock (ZI)
Apple Common stock (AAPL)
Spdr S&p 500 Etf Exchange traded fund (SPY)
Microsoft Corp Common stock (MSFT)
Amazon.com Common stock (AMZN)
Broadcom Common stock (AVGO)
Ally Financial Common stock (ALLY)
Nrg Energy Common stock (NRG)
International Business Machine Common stock (IBM)
Jpmorgan Chase & Co Common stock (JPM)
Abbvie Common stock (ABBV)
Home Depot Common stock (HD)
Comerica Common stock (CMA)
Clearway Energy Inc Cl C Common stock (CWEN)

View all positions for Green Square Asset Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Susquehanna International
Ubs Global Asset Management Americas
Charles Schwab Investment Management

View all funds holding Regeneron Pharmaceuticals